Research & Reviews: Journal of Oncology and Hematology

ISSN: 2319-3387

Editors Overview

rrjooh maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.

Open Access
Special Issue

Chemotherapy Adverse Effects

Abstract Submission Deadline : November 30, 2023

Manuscript Submission Deadline : December 25, 2023

Special Issue Description

Cancer is an illness brought about by an uncontrolled division of abnormal cells in a part of the body. There are various techniques for therapy relying upon organ type, phase of cancer, state of cells, and disease as the subsequent driving reason for death around the world. Chemotherapy is a standard methodology of cancer therapy that utilizes substance specialists or medications to obliterate disease cells in the cell cycles or use synthetics or medications to restrain malignant cells’ development and spread. Chemotherapy is an essential therapy methodology for some tumors and advancing new anti-cancer drugs addresses one of the biggest drug improvement areas. Chemotherapy has its benefits and faults as the treatment influences both the physiological and mental parts of human existence. i.e., torment, rest unsettling influences, sickness, vomiting, stress, nervousness, gastrointestinal issues, bleeding, easy bruising, mouth sores, fever, etc. Chemotherapy medications can likewise cause incidental effects that don’t become apparent until months or years after treatment. Late secondary effects change contingent upon the chemotherapy drug however can include damage to lung tissue, heart problems, infertility, kidney problems, nerve damage (peripheral neuropathy), and risk of second cancer. New ways to deal with further develop resilience and diminish disease chemotherapy are direly required. Chemotherapy-induced peripheral neuropathy (CIPN) is brought about by numerous anti- malignant growth drugs including platinum-based specialists, vinca alkaloids, taxanes, and proteasome and angiogenesis inhibitors.


Cancer, Chemotherapy, Drugs, Chemotherapy-induced peripheral neuropathy (CIPN), Infertility

Manuscript Submission information

Manuscripts should be submitted online via the manuscript Engine. Once you register on APID, click here to go to the submission form. Manuscripts can be submitted until the deadline.
All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the email address:[email protected] for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a Double-blind peer-review process. A guide for authors and other relevant information for the submission of manuscripts is available on the Instructions for Authors page.

Participating journals: